Endometrioid carcinoma of prostate.
Odom DG, Westphal KW, Hawksley VC, Deshon GE.
Urology. 1988 Mar;31(3):217-9. doi: 10.1016/0090-4295(88)90143-4.
Clinicopathological correlations of endometrioid and clear cell carcinomas in the uterus and ovary.
Mori H, Nishida H, Kusaba T, Kawamura K, Oyama Y, Daa T.
Medicine (Baltimore). 2023 Sep 15;102(37):e35301. doi: 10.1097/MD.0000000000035301.
Role of radiotherapy in ductal (endometrioid) carcinoma of the prostate.
Eade TN, Al-Saleem T, Horwitz EM, Buyyounouski MK, Chen DY, Pollack A.
Cancer. 2007 May 15;109(10):2011-5. doi: 10.1002/cncr.22644.
Endometrioid Squamous Proliferations of the Endometrium Express Alpha-Methylacyl-CoA Racemase (P504s).
Tahir M, Samankan S, Huang M, Pinto A.
Int J Gynecol Pathol. 2023 Nov 1;42(6):576-581. doi: 10.1097/PGP.0000000000000931. Epub 2023 Aug 10.
Endometrioid carcinoma of the prostate. The diagnostic value of Leu7 and prostatic specific antigen.
Stavropoulos NE, Ioackim-Velogianni E, Sidoni K, Stefanou D, Klouvas G, Pavlidis N.
Br J Urol. 1993 Mar;71(3):309-12. doi: 10.1111/j.1464-410x.1993.tb15948.x.
Unusual prostatic carcinomas.
Dhom G.
Pathol Res Pract. 1990 Feb;186(1):28-36. doi: 10.1016/S0344-0338(11)81009-5.
Ductal adenocarcinoma of the prostate with endometrioid features in a 69-year-old man.
Cheng CJ, Chen KC, Chen WY, Su SJ.
J Formos Med Assoc. 2001 Oct;100(10):707-11.
Variant prostate carcinoma and elevated serum CA-125.
Bilen MA, Reyes A, Bhowmick D, Maa A, Bast R Jr, Pisters LL, Lin SH, Logothetis CJ, Tu SM.
Can J Urol. 2014 Oct;21(5):7442-8.
Papillary carcinoma of the prostate, location, morphology, and immunohistochemistry: the histogenesis and entity of so-called endometrioid carcinoma.
Wernert N, Lüchtrath H, Seeliger H, Schäfer M, Goebbels R, Dhom G.
Prostate. 1987;10(2):123-31. doi: 10.1002/pros.2990100204.
Histologic variants of adenocarcinoma and other carcinomas of prostate: pathologic criteria and clinical significance.
Randolph TL, Amin MB, Ro JY, Ayala AG.
Mod Pathol. 1997 Jun;10(6):612-29.
